Syngoi Technologies is a CDMO (Contract Development and Manufacturing Organization) specializing in the production of synthetic DNA for advanced cell and gene therapies. Founded in 2021 by Columbus VP, the company is headquartered in the Zamudio Technology Park (Bizkaia, Spain). Syngoi has developed and patented innovative cell-free production methods that enable the synthesis of DNA with natural and/or modified nucleotides, incorporating adapters tailored to client needs. This scalable and customizable process ensures manufacturing under GMP conditions, offering high efficiency, cost-effectiveness, high fidelity, and significantly faster production compared to traditional pDNA methods.